Westhaus, Adrian
Eamegdool, Steven S.
Fernando, Milan
Fuller-Carter, Paula
Brunet, Alicia A.
Miller, Annie L.
Rashwan, Rabab
Knight, Maddison
Daniszewski, Maciej
Lidgerwood, Grace E.
Pébay, Alice
Hewitt, Alex
Santilli, Giorgia
Thrasher, Adrian J.
Carvalho, Livia S.
Gonzalez-Cordero, Anai
Jamieson, Robyn V.
Lisowski, Leszek
Funding for this research was provided by:
NHMRC Senior Research Fellowship (APP1154389)
The Wellcome Trust (217112/Z/19/Z AJT)
Paediatrio Paediatric Precision Medicine Program (PPM1 K5116/RD274, PPM1 K5116/RD274)
MRFF Stem Cell Therapies Mission (2021/MRF2008912)
Australian National Health and Medical Research Council (APP1108311)
National Science Centre, Republic of Poland (OPUS 13-UMO-2017/25/B/NZ1/02790)
Article History
Received: 24 August 2023
Accepted: 4 December 2023
First Online: 11 December 2023
Competing interests
: L.L. and A.J.T. have commercial affiliations. L.L. has consulted on technologies discussed in this paper. L.L. has stock and/or equity in companies with technologies broadly related to this study. L.L., A.W., A.G.-C., S.S.E., and R.V.J. are co-inventors of, and receive licensing royalties from, several AAV variants used in the study. All other authors declare no competing financial interests.